Raras
Buscar doenças, sintomas, genes...
Paralisia periódica genética
ORPHA:371433CID-11 · 8C74.1DOENÇA RARA

Grupo de distúrbios neurológicos genéticos causados ​​por mutações em genes envolvidos nos canais de sódio e cálcio nas células nervosas. É caracterizada por episódios de paralisia muscular em que os músculos afetados ficam flácidos e os reflexos tendinosos profundos desaparecem. Entre os episódios os músculos afetados geralmente funcionam normalmente.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Grupo de distúrbios neurológicos genéticos causados ​​por mutações em genes envolvidos nos canais de sódio e cálcio nas células nervosas. É caracterizada por episódios de paralisia muscular em que os músculos afetados ficam flácidos e os reflexos tendinosos profundos desaparecem. Entre os episódios os músculos afetados geralmente funcionam normalmente.

🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

💪
Músculos
18 sintomas
😀
Face
15 sintomas
🦴
Ossos e articulações
12 sintomas
❤️
Coração
11 sintomas
🧠
Neurológico
8 sintomas
📏
Crescimento
8 sintomas

+ 53 sintomas em outras categorias

Características mais comuns

Face triangular
Retenção urinária
Constipação
Doença de Graves
Hipofosfatemia transitória
Hiperidrose
142sintomas
Sem dados (142)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 142 características clínicas mais associadas, ordenadas por frequência.

Face triangularTriangular face
Retenção urináriaUrinary retention
ConstipaçãoConstipation
Doença de GravesGraves disease
Hipofosfatemia transitóriaTransient hypophosphatemia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa7
Últimos 10 anos200publicações
Pico202038 papers
Linha do tempo
20202019Hoje · 2026🧪 1992Primeiro ensaio clínico📈 2020Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

9 genes identificados com associação a esta condição.

KCNJ2Inward rectifier potassium channel 2Disease-causing germline mutation(s) inModerado
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:36149965, PubMed:7590287, PubMed:9490857). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:7590287, PubMed:7696590). The inward rectification is mainly due to the blockage of outward current by inter

LOCALIZAÇÃO

Cell membraneCell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (5)
Activation of G protein gated Potassium channelsInhibition of voltage gated Ca2+ channels via Gbeta/gamma subunitsClassical Kir channelsPhase 4 - resting membrane potentialSensory perception of sour taste
MECANISMO DE DOENÇA

Long QT syndrome 7

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Long QT syndrome type 7 manifests itself as a clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
10.1 TPM
Brain Spinal cord cervical c-1
9.1 TPM
Sangue
6.5 TPM
Coração - Ventrículo esquerdo
5.5 TPM
Mama
5.1 TPM
OUTRAS DOENÇAS (5)
short QT syndrome type 3Andersen-Tawil syndromeatrial fibrillation, familial, 9short QT syndrome
HGNC:6263UniProt:P63252
KCNJ5G protein-activated inward rectifier potassium channel 4Candidate gene tested inTolerante
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by external barium. This potassium channel is control

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (2)
Activation of G protein gated Potassium channelsInhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
MECANISMO DE DOENÇA

Long QT syndrome 13

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
62.9 TPM
Pituitária
25.4 TPM
Baço
10.2 TPM
Pâncreas
8.2 TPM
Rim - Medula
6.3 TPM
OUTRAS DOENÇAS (5)
familial hyperaldosteronism type IIIlong QT syndrome 13familial atrial fibrillationAndersen-Tawil syndrome
HGNC:6266UniProt:P48544
KCNJ18Inward rectifier potassium channel 18Candidate gene tested inTolerante
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum

MECANISMO DE DOENÇA

Thyrotoxic periodic paralysis 2

A sporadic muscular disorder characterized by episodic weakness and hypokalemia during a thyrotoxic state. It is clinically similar to hereditary hypokalemic periodic paralysis, except for the fact that hyperthyroidism is an absolute requirement for disease manifestation. The disease presents with recurrent episodes of acute muscular weakness of the four extremities that vary in severity from paresis to complete paralysis. Attacks are triggered by ingestion of a high carbohydrate load or strenuous physical activity followed by a period of rest. Thyrotoxic periodic paralysis can occur in association with any cause of hyperthyroidism, but is most commonly associated with Graves disease.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Not Sun Exposed Suprapubic
10.2 TPM
Skin Sun Exposed Lower leg
8.5 TPM
Testículo
1.2 TPM
Cérebro - Hemisfério cerebelar
0.1 TPM
Cerebelo
0.1 TPM
OUTRAS DOENÇAS (2)
thyrotoxic periodic paralysisthyrotoxic periodic paralysis, susceptibility to, 2
HGNC:39080UniProt:B7U540
KCNE3Potassium voltage-gated channel subfamily E member 3Candidate gene tested inModerado
FUNÇÃO

Ancillary protein that functions as a regulatory subunit of the voltage-gated potassium (Kv) channel complex composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits. KCNE3 beta subunit modulates the gating kinetics and enhances stability of the channel complex (PubMed:10646604, PubMed:11207363, PubMed:12954870). Alters the gating of the delayed rectifier Kv channel containing KCNB1 alpha subunit (PubMed:12954870). Associates with KCNC4/Kv3.4 alpha subunit

LOCALIZAÇÃO

Cell membraneCytoplasmPerikaryonCell projection, dendriteMembrane raft

VIAS BIOLÓGICAS (2)
Phase 3 - rapid repolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

Brugada syndrome 6

A tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
18.2 TPM
Intestino delgado
12.5 TPM
Baço
11.1 TPM
Ovário
10.2 TPM
Glândula salivar
10.1 TPM
OUTRAS DOENÇAS (3)
Brugada syndrome 6Brugada syndromehypokalemic periodic paralysis
HGNC:6243UniProt:Q9Y6H6
GABRA3Gamma-aminobutyric acid receptor subunit alpha-3Candidate gene tested inRestrito
FUNÇÃO

Alpha subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:16412217, PubMed:29053855). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride an

LOCALIZAÇÃO

Postsynaptic cell membraneCell membrane

VIAS BIOLÓGICAS (1)
GABA receptor activation
MECANISMO DE DOENÇA

Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features

A neurologic disorder characterized by variable combinations of epileptic seizure, and a varying degree of intellectual disability and developmental delay. Some patients have dysmorphic facial features or mild skeletal anomalies. In general, males are more severely affected than females, although there is evidence for incomplete penetrance in both sexes.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
20.7 TPM
Brain Anterior cingulate cortex BA24
13.6 TPM
Hipotálamo
13.3 TPM
Córtex cerebral
12.6 TPM
Brain Nucleus accumbens basal ganglia
6.9 TPM
OUTRAS DOENÇAS (2)
epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic featuresthyrotoxic periodic paralysis
HGNC:4077UniProt:P34903
MT-ATP6ATP synthase F(0) complex subunit aCandidate gene tested inDesconhecido
FUNÇÃO

Subunit a, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside the F(1

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Mitochondrial translation terminationFormation of ATP by chemiosmotic couplingCristae formationMitochondrial protein degradation
MECANISMO DE DOENÇA

Neuropathy, ataxia, and retinitis pigmentosa

A syndrome characterized by variable combination of developmental delay, psychomotor retardation, hearing loss, optic atrophy and retinitis pigmentosa, dementia, seizures, ataxia, proximal neurogenic muscle weakness, and sensory neuropathy.

OUTRAS DOENÇAS (8)
mitochondrial diseasematernally-inherited Leigh syndromefamilial infantile bilateral striatal necrosismitochondrial proton-transporting ATP synthase complex deficiency
HGNC:7414UniProt:P00846
MT-ATP8ATP synthase F(0) complex subunit 8Candidate gene tested inDesconhecido
FUNÇÃO

Subunit 8, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside

LOCALIZAÇÃO

Mitochondrion membrane

VIAS BIOLÓGICAS (3)
Mitochondrial translation terminationFormation of ATP by chemiosmotic couplingCristae formation
MECANISMO DE DOENÇA

Mitochondrial complex V deficiency, mitochondrial 2

A mitochondrial disorder with heterogeneous clinical manifestations including neuropathy, ataxia, hypertrophic cardiomyopathy. Hypertrophic cardiomyopathy can present with negligible to extreme hypertrophy, minimal to extensive fibrosis and myocyte disarray, absent to severe left ventricular outflow tract obstruction, and distinct septal contours/morphologies with extremely varying clinical course.

OUTRAS DOENÇAS (4)
mitochondrial diseaseperiodic paralysis with later-onset distal motor neuropathymitochondrial proton-transporting ATP synthase complex deficiencyKearns-Sayre syndrome
HGNC:7415UniProt:P03928
CACNA1SVoltage-dependent L-type calcium channel subunit alpha-1SDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Pore-forming, alpha-1S subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents in skeletal muscle. Calcium channels containing the alpha-1S subunit play an important role in excitation-contraction coupling in skeletal muscle via their interaction with RYR1, which triggers Ca(2+) release from the sarcoplasmic reticulum and ultimately results in muscle contraction. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group

LOCALIZAÇÃO

Cell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (1)
NCAM1 interactions
MECANISMO DE DOENÇA

Periodic paralysis hypokalemic 1

An autosomal dominant disorder manifested by episodic flaccid generalized muscle weakness associated with falls of serum potassium levels.

VIAS REACTOME (1)
OUTRAS DOENÇAS (8)
congenital myopathy 18hypokalemic periodic paralysis, type 1malignant hyperthermia of anesthesiaobsolete periodic paralysis with transient compartment-like syndrome
HGNC:1397UniProt:Q13698
SCN4ASodium channel protein type 4 subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Pore-forming subunit of Nav1.4, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Paramyotonia congenita

An autosomal dominant channelopathy characterized by myotonia, increased by exposure to cold, intermittent flaccid paresis, not necessarily dependent on cold or myotonia, lability of serum potassium, non-progressive nature and lack of atrophy or hypertrophy of muscles. In some patients, myotonia is not increased by cold exposure (paramyotonia without cold paralysis). Patients may have a combination phenotype of PMC and HYPP.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
80.7 TPM
Adipose Visceral Omentum
29.9 TPM
Mama
21.0 TPM
Tecido adiposo
18.1 TPM
Tireoide
10.4 TPM
OUTRAS DOENÇAS (12)
potassium-aggravated myotoniacongenital myopathy 22A, classiccongenital myopathy 22B, severe fetalhyperkalemic periodic paralysis
HGNC:10591UniProt:P35499

Variantes genéticas (ClinVar)

305 variantes patogênicas registradas no ClinVar.

🧬 KCNJ2: NM_000891.3(KCNJ2):c.647A>G (p.Asn216Ser) ()
🧬 KCNJ2: NM_000891.3(KCNJ2):c.351del (p.Glu118fs) ()
🧬 KCNJ2: NM_000891.3(KCNJ2):c.557C>G (p.Pro186Arg) ()
🧬 KCNJ2: NM_000891.3(KCNJ2):c.*2776G>T ()
🧬 KCNJ2: NM_000891.3(KCNJ2):c.1009T>C (p.Tyr337His) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Paralisia periódica genética

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

The importance of comprehensive diagnostic work-up and genetic testing to reveal Andersen-Tawil syndrome-a case report.

European heart journal. Case reports2026 Feb

Andersen-Tawil syndrome is characterized by a symptom triad of cardiac electrical abnormalities, periodic muscular paralysis, and distinct dysmorphic manifestations. A history of unexplained syncope has been associated with a more serious phenotype with increased risk of life-threatening arrhythmia. Due to the syndrome's rarity and highly variable clinical presentation, diagnosis remains challenging. This report highlights the importance of comprehensive diagnostic workup following a sudden cardiac arrest, particularly emphasizing the value of genetic testing. We present a 61-year-old male hypertensive patient who initially presented with a first-time syncopal episode. Initial investigations revealed ventricular ectopy exceeding 12 000 premature ventricular contractions, occasional QT prolongation of >500 ms, and mildly reduced left ventricular ejection fraction (50%). Outpatient diagnostic investigations did not yield a diagnosis. While awaiting ablation, the patient suffered from an out-of-hospital cardiac arrest and was successfully resuscitated after 17 min. Complete diagnostic work-up including guideline-adherent assessments and genetic testing eventually revealed Andersen-Tawil syndrome. The subsequent family evaluations supported the diagnosis. Diagnosis was unexpected as the patient presented with isolated cardiac manifestations and a late onset of symptoms. Cardiomyopathy and primary arrhythmic disorders were relevant differential diagnoses and investigated during admission. No clinical assessment is pathognomonic for Andersen-Tawil syndrome, making genetic testing essential for establishing a definitive diagnosis. While historically characterized as a long QT variant, research suggests Andersen-Tawil syndrome is its own disease entity. Pharmacological management follows established channelopathy principles, though the protective efficacy of beta-blockers and flecainide remains uncertain in this syndrome.

#2

Case Report of Andersen-Tawil Syndrome: Rare Presentation of a Rare Disease.

Annals of Indian Academy of Neurology2026 Jan 01

Andersen-Tawil syndrome (ATS) is a rare genetic disorder characterized by a triad of periodic paralysis, cardiac arrhythmias, and dysmorphic features, typically presenting in the first two decades of life. A 45-year-old man presented with acute lower motor neuron-type quadriparesis. He reported similar self-resolving episodes over the past 2 years, triggered by rest after exercise. There were no cardiac symptoms, dysmorphic features, or relevant family history. Biochemical evaluation revealed hypokalemia. Genetic testing confirmed a heterozygous nonsense mutation in the KCNJ2 gene (c.13C>T, p.Arg5Ter). Cardiac and dental evaluations were normal. He was treated with potassium supplementation and later acetazolamide, with no recurrence over 2 years. This case highlights a rare adult-onset presentation of ATS without cardiac or dysmorphic features and a negative family history, contributing to the limited adult ATS literature.

#3

Novel CACNA1S Mutation c.3491 A>C in Hypokalemic Periodic Paralysis: First Report with Functional Validation.

Journal of molecular neuroscience : MN2026 Feb 04

Hypokalemic periodic paralysis (HypoPP) is a muscle disease caused by abnormal ion channels and is characterized by recurrent skeletal muscle relaxation paralysis and hypokalemia. There are obvious triggers before disease onset, such as cold, excessive exercise, excessive consumption of sugary and high-energy foods, and overeating. The aim of this study was to elucidate the pathogenic mechanism of novel mutations in the voltage-dependent L-type calcium channel subunit alpha-1 S (CACNA1S) gene associated with HypoPP. Method: Whole-exome sequencing and American College of Medical Genetics and Genomics (ACMG) compliance analysis were performed, supplemented by serum potassium and blood biochemistry tests for bioinformatics analysis. We report a 13-year-old adolescent male patient with hypokalemic periodic paralysis, who complained of limb muscle weakness accompanied by pain for 10 h. Whole-exome sequencing revealed a mutation in the CACNA1S gene (NM_000069.3: exon27: c.3491 A>C [p. Glu1164Ala]), which was classified as an uncertain mutation. The clinical presentation and protein structure prediction of the gene mutation confirmed its pathogenic role and mechanism. The mutation caused a conformational change in the calcium ion channel. This study revealed a new mutation site in the HypoPP gene and proposed the possibility of a new pathogenesis. Moreover, obesity and low magnesium are two factors that induce HypoPP, which may increase the risk of disease.

#4

Sex determination and genetic screening of equine embryos with whole genome amplification and real-time PCR.

The Journal of reproduction and development2026 Mar 23

Reliable pre-implantation sex determination and genetic screening enables informed embryo transfer decisions in equine breeding while avoiding later interventions. We developed a streamlined workflow that couples rapid whole genome amplification (WGA) with a multiplex real-time PCR targeting ETSTY5 as a Y-specific marker and UBC as an autosomal control. On purified equine DNA, sex was correctly assigned down to 10 pg gDNA and to a single fibroblast cell. Direct testing of embryo biopsies without WGA yielded inconsistent results, whereas introducing a short WGA step produced tight allelic-discrimination clusters and 100% diagnostic calls, including in cloned embryos of known sex. The same WGA product supported targeted genotyping for inherited disease screening of hyperkalemic periodic paralysis (HYPP) and hereditary equine regional dermal asthenia (HERDA) alleles. This WGA plus real-time PCR pipeline supports robust and practical embryo sexing and targeted pre-implantation genetic diagnostics within in vitro produced (IVP) equine embryo and embryo transfer workflows.

#5

Clinical features and advances in the genetics of periodic paralysis.

PeerJ2026

Periodic paralysis (PP) is a group of ion channel diseases with incomplete autosomal dominant inheritance, except in sporadic patients. Ion channel gene mutations cause transient abnormalities in skeletal muscle excitability and muscle weakness. Different mutation sites cause different pathogenesis, which is very important for the classification, clinical manifestations, treatment and prognosis of periodic paralysis. Currently, the recognized mutated genes are CACNA1S (chromosome 1q31-32), SCN4A (chromosome 17q23-25), KCNJ2 (chromosome 17q23), and KCNJ18 (chromosome 17p11.2). The common mutation sites include R528H and R1239H in CACNA1S, and R672H and T704M in SCN4A. However, there is accumulating evidence that other mutation sites in CACNA1S and SCN4A, and even new ion channel mutations may induce periodic paralysis. Their different pathogenesis, clinical features and therapeutic measures have been widely described. This review will introduce the clinical manifestations of periodic paralysis, the different mutation sites of each ion channel, and the pathogenesis. Based on the clinical types of periodic paralysis, the characteristics of the latter are further discussed.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 196

2026

Sex determination and genetic screening of equine embryos with whole genome amplification and real-time PCR.

The Journal of reproduction and development
2026

Clinical features and advances in the genetics of periodic paralysis.

PeerJ
2025

Case Report: Dominant deafness-onychodystrophy syndrome and hypokalemic periodic paralysis in a single patient: a rare syndromic overlap.

Frontiers in pediatrics
2026

The Clinical, Histological, and Genetic Spectrum of RYR1 Variants-A Multi-Center Israeli Cohort Study.

Journal of clinical medicine
2026

The importance of comprehensive diagnostic work-up and genetic testing to reveal Andersen-Tawil syndrome-a case report.

European heart journal. Case reports
2026

Case Report of Andersen-Tawil Syndrome: Rare Presentation of a Rare Disease.

Annals of Indian Academy of Neurology
2026

Novel CACNA1S Mutation c.3491 A>C in Hypokalemic Periodic Paralysis: First Report with Functional Validation.

Journal of molecular neuroscience : MN
2026

Efficacy of a K+ Channel Agonist, XEN1101, For Preserving Contractility in Mouse Models of Hypokalemic Periodic Paralysis.

Muscle & nerve
2026

Hypokalemic Periodic Paralysis Associated With a Rare CACNA1S Variant (p.Leu1243Val): Expanding the Mutational Spectrum.

Case reports in genetics
2026

Efficacy of Retigabine in Treating Weakness in a Mouse Model of Hypokalemic Periodic Paralysis.

Muscle & nerve
2025

A Pediatric Case of Hypokalemic Periodic Paralysis With Fatigue and Myalgia.

Cureus
2025

Thyrotoxic Periodic Paralysis (TPP): A Comprehensive Review with Regional Insights from the Middle East.

Cureus
2026

[Functional analysis of the mutant channels associated with skeletal muscle channelopathies].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
2026

Perinatal Management of Andersen-Tawil Syndrome Using a Wearable Cardioverter-Defibrillator: A Case Report.

The journal of obstetrics and gynaecology research
2025

Thyrotoxic Hypokalemic Periodic Paralysis: Pathophysiological Mechanisms.

Endocrinology and metabolism (Seoul, Korea)
2026

Nonthyroidal illness syndrome and diagnostic utility of CSF mNGS: insights from a case series of neurological scrub typhus.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2025

Exploring Etiologies of Hypokalemic Paralysis: A Case Series.

The Journal of the Association of Physicians of India
2026

Genetic Study of a Greek Family with Hypokalemic Periodic Paralysis in Four Generations.

Advances in experimental medicine and biology
2025

Hypokalemic Periodic Paralysis: A Case Report.

Cureus
2025

Sudden Tetraplegia from Hypokalaemic Periodic Paralysis Due to Cacna1s Mutation: Should Genetic Testing be Performed More Often?

European journal of case reports in internal medicine
2025

Muscle Channelopathies and Rhabdomyolysis.

Continuum (Minneapolis, Minn.)
2025

Genetic analysis of a family with skeletal muscle ion channelopathy and hereditary spastic paraplegia type 7 caused by SCN4A and SPG7 double mutations.

Gene
2025

Clinical and molecular mechanistic insights into the WDR72 mutation.

BMJ case reports
2025

Redefining periodic paralysis with CACNA1S mutation in a Spanish cohort.

Neurologia
2025

Generation of three iPSC lines from patients with CACNA1S related congenital myopathy.

Stem cell research
2025

COVID-19 infection and intense physical activity in hypokalemic periodic paralysis.

Boletin medico del Hospital Infantil de Mexico
2025

Molecular genetics of skeletal muscle channelopathies.

Journal of human genetics
2025

Hypokalemic periodic paralysis associated with the atypical CACNA1S c.2690G>A (p.Arg897Lys) variant: description of 14 affected individuals from five families.

Neuromuscular disorders : NMD
2025

Exploring self-management of diet and physical activity in CACNA1S-related hypokalemic periodic paralysis: A qualitative interview study.

Journal of neuromuscular diseases
2025

Semaglutide reverses the chronic myopathy of hyperkalemic periodic paralysis: a case report.

BMC nephrology
2025

Atypical Electrophysiological Pattern in Hypokalemic Periodic Paralysis With CACNA1S Mutation: A Case Report.

Cureus
2025

Potassium-sensitive loss of muscle force in the setting of reduced inward rectifier K+ current: Implications for Andersen-Tawil syndrome.

Proceedings of the National Academy of Sciences of the United States of America
2025

Broadening the Phenotypic Range: KCNJ2 Variant Linked to Isolated Periodic Paralysis with Fixed Myopathy.

Annals of Indian Academy of Neurology
2025

STIM1 in-frame deletion of eight amino acids in a patient with moderate tubular aggregate myopathy/Stormorken syndrome.

Journal of medical genetics
2025

How nutrigenomics impacts equine health - A case study of vitamin E.

Journal of equine veterinary science
2025

CACNA1S-associated triadopathy presenting with myalgia, muscle weakness, and asymptomatic hyperCKemia.

Therapeutic advances in neurological disorders
2024

Novel mutation in KCNJ2 gene causes long QT interval syndrome type 7 and learning disability: A case report.

Medicine
2024

[Hypokalemia: Not Just Tubulopathies].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
2025

Mechanisms underlying the distinct K+ dependencies of periodic paralysis.

The Journal of general physiology
2025

Genetics of Muscle Disease.

The Veterinary clinics of North America. Equine practice
2024

Atypical Presentation of Andersen-Tawil Syndrome: Heart Failure with Reduced Ejection without Periodic Paralysis or Dysmorphic Features.

European journal of case reports in internal medicine
2024

Periodic paralysis across the life course: age-related phenotype transition and sarcopenia overlap.

Frontiers in neurology
2025

Muscle Contractility in Hypokalemic Periodic Paralysis.

Muscle & nerve
2024

Functional ultrasound and brain connectivity reveal central nervous system compromise in Trembler-J mice model of Charcot-Marie-Tooth disease.

Scientific reports
2024

Bartter Syndrome With Recurrent Hypokalemic Periodic Paralysis: A Case Report.

Cureus
2024

Hypokalemic periodic paralysis presenting as cardiac arrest.

BMJ case reports
2024

[Andersen-Tawil Syndrome, a differential of bidirectional ventricular tachycardia: a case report].

Archivos peruanos de cardiologia y cirugia cardiovascular
2024

A Novel CLCN1 Gene Mutation Associated with Hypokalemic Periodic Paralysis in a Pregnant Woman.

The Israel Medical Association journal : IMAJ
2025

Periodic Paralysis in a Child With Thermosensitive Mitochondrial Trifunctional Protein Deficiency.

American journal of medical genetics. Part A
2024

Clinical, myopathological, and genetic features of two Chinese families with Andersen-Tawil syndrome.

Frontiers in neurology
2024

Familial hypokalemic periodic paralysis: a case induced by concurrent hyperthyroidism.

BMC nephrology
2024

Thyrotoxic periodic paralysis complicated by carbimazole-associated myositis.

BMJ case reports
2025

Genetic background of neonatal hypokalemia.

Pediatric nephrology (Berlin, Germany)
2024

A Late Diagnosis of Andersen-Tawil Syndrome in Teenage Siblings.

Pediatric neurology
2024

Pediatric neuromuscular channelopathies.

Handbook of clinical neurology
2024

Core myopathy in two siblings with a biallelic variant in the CACNA1S gene-A case series study.

Clinical case reports
2024

[A case report of a MODY 10 family presenting as hypokalemic periodic paralysis].

Zhonghua nei ke za zhi
2024

Quality of life in hypokalemic periodic paralysis - a survey.

Neuromuscular disorders : NMD
2024

Early-Onset Autosomal Dominant Myopathy with Vacuolated Fibers and Tubular Aggregates but No Periodic Paralysis, in a Patient with the c.1583G>A (p.R528H) mutation in the CACNA1S Gene.

Journal of neuromuscular diseases
2024

Atypical Normokalemic Case of Thyrotoxic Periodic Paralysis in a Pediatric Patient.

Cureus
2024

Hyperkalemic Periodic Paralysis Secondary to End-Stage Renal Disease and Excess Potato Consumption.

Cureus
2024

Phenotypic Variability of Andersen-Tawil Syndrome Due to Allelic Mutation c.652C>T in the KCNJ2 Gene-A New Family Case Report.

Biomolecules
2024

Genetic analysis of 37 cases with primary periodic paralysis in Chinese patients.

Orphanet journal of rare diseases
2024

Novel compound heterozygous mutations in SCN4A as a potential genetic cause contributing to myopathic manifestations: A case report and literature review.

Heliyon
2024

Allele frequency of muscular genetic disorders in bull-catching (vaquejada) quarter horses.

Journal of equine veterinary science
2024

Transcriptome and open chromatin analysis reveals the process of myocardial cell development and key pathogenic target proteins in Long QT syndrome type 7.

Journal of translational medicine
2024

Hypokalemic Periodic Paralysis Type 2 Due to SCN4A Val1105Met Mutation: A Case Study.

Cureus
2024

Special electromyographic features in a child with paramyotonia congenita: A case report and review of literature.

World journal of clinical cases
2024

Crossover randomized controlled trial of bumetanide to rescue an attack of exercise induced hand weakness in hypokalaemic periodic paralysis.

Neuromuscular disorders : NMD
2024

A retrospective study of accuracy and usefulness of electrophysiological exercise tests.

Journal of neurology
2023

Newly Diagnosed Hypokalemic Periodic Paralysis Triggered by COVID-19.

Cureus
2023

Diagnostics in skeletal muscle channelopathies.

Expert review of molecular diagnostics
2024

Prevalence and risk factors of low vitamin D levels in children and adolescents with familial hypokalemic periodic paralysis.

European journal of pediatrics
2023

Case report: A novel CACNA1S mutation associated with hypokalemic periodic paralysis.

Frontiers in neurology
2023

A novel CACNA1S gene variant in a child with hypokalemic periodic paralysis: a case report and literature review.

BMC pediatrics
2023

Hypokalemic periodic paralysis: a 3-year follow-up study.

Journal of neurology
2023

Two Cases of Periodic Paralysis Associated With MCM3AP Variants.

Journal of clinical neuromuscular disease
2023

Muscle MRI in periodic paralysis shows myopathy is common and correlates with intramuscular fat accumulation.

Muscle & nerve
2024

Potential Benefit of Channel Activators in Loss-of-Function Primary Potassium Channelopathies Causing Heredoataxia.

Cerebellum (London, England)
2023

A case report of Andersen-Tawil syndrome misdiagnosed with myodystrophy.

Frontiers in neurology
2023

Code Pseudo Stroke - A Case of Hypokalaemic Periodic Paralysis Mimicking Stroke.

European journal of case reports in internal medicine
2023

Care Recommendations for the Investigation and Management of Children With Skeletal Muscle Channelopathies.

Pediatric neurology
2023

Panic Attack, Severe Hypophosphatemia and Rhabdomyolysis in the Setting of a Motor Functional Neurological Disorder.

Brain sciences
2023

Optical measurement of gating pore currents in hypokalemic periodic paralysis model cells.

Disease models & mechanisms
2023

Gitelman syndrome with Graves' disease leading to rhabdomyolysis: a case report and literature review.

BMC nephrology
2023

Thyrotoxic periodic paralysis in a Caucasian man without identifiable genetic predisposition: a case report.

Thyroid research
2023

Sinus arrest in familial hypokalemic periodic paralysis caused by SCN4A mutation: a case report.

European review for medical and pharmacological sciences
2023

Thyrotoxic Periodic Paralysis With Severe Hypokalemia Precipitated by Acute Alcohol Intoxication in a Patient With Graves' Disease.

Cureus
2023

Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing.

Neuromuscular disorders : NMD
2023

Muscle fat replacement and contractility in patients with skeletal muscle sodium channel disorders.

Scientific reports
2023

Gene panel analysis of 119 index patients with suspected periodic paralysis in Japan.

Frontiers in neurology
2023

Thyrotoxic periodic paralysis associated with lactic metabolic acidosis: Case report of an African man and review of literature.

Annales d'endocrinologie
2022

Case report: SCN4A p.R1135H gene variant in combination with thyrotoxicosis causing hypokalemic periodic paralysis.

Frontiers in neurology
2023

Pathophysiologic approach in genetic hypokalemia: An update.

Annales d'endocrinologie
2023

Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4.

Brain & development
2023

Drug repurposing in skeletal muscle ion channelopathies.

Current opinion in pharmacology
2023

Atypical presentation of hypokalemic periodic paralysis: A case report.

Muscle & nerve
2022

Hypokalemic Periodic Paralysis Exacerbated by Carbohydrate Load: A Case Report.

Cureus
2022

Novel compound heterozygous mutation of SLC12A3 in Gitelman syndrome co-existent with hyperthyroidism: A case report and literature review.

World journal of clinical cases
2022

Prevalence of Genetic Mutations in Horses With Muscle Disease From a Neuromuscular Disease Laboratory.

Journal of equine veterinary science
2022

Periodic paralysis due to cumulative effects of rare variants in SCN4A with small functional alterations.

Muscle & nerve
2022

Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome.

Frontiers in cardiovascular medicine
2022

Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis.

Frontiers in neurology
2022

European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders.

European journal of neurology
2023

Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome.

Cardiovascular research
2022

A dangerous food binge: a case report of hypokalemic periodic paralysis and review of current literature.

Italian journal of pediatrics
2022

Voltage-dependent Ca2+ release is impaired in hypokalemic periodic paralysis caused by CaV1.1-R528H but not by NaV1.4-R669H.

American journal of physiology. Cell physiology
2022

Childbirth with epidural analgesia in a pregnant woman with hypokalemic periodic paralysis.

Revista espanola de anestesiologia y reanimacion
2022

Phenotypical variability and atypical presentations in a French cohort of Andersen-Tawil syndrome.

European journal of neurology
2022

Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome.

European journal of medical genetics
2021

Atypical Fracture of Femur in Association with Familial Hypokalemic Periodic Paralysis: A Case Report.

Journal of orthopaedic case reports
2022

Development of high-affinity nanobodies specific for NaV1.4 and NaV1.5 voltage-gated sodium channel isoforms.

The Journal of biological chemistry
2021

Ageing contributes to phenotype transition in a mouse model of periodic paralysis.

JCSM rapid communications
2021

Andersen-Tawil Syndrome With Novel Mutation in KCNJ2: Case Report.

Frontiers in pediatrics
2022

Refractory familial hypokalaemic periodic paralysis leading to cardiovascular compromise.

BMJ case reports
2022

Novel CACNA1S mutation in hypokalaemic periodic paralysis.

BMJ case reports
2022

Andersen-Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity.

Brain : a journal of neurology
2021

Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome.

Frontiers in genetics
2022

The long exercise test as a functional marker of periodic paralysis.

Muscle & nerve
2021

Vacuolar Myopathy Associated to CACNA1S Mutation as a Rare Cause of Late-Onset Limb-Girdle Myopathy: A Case Report.

Cureus
2021

Case Report: A Novel CACNA1S Mutation Associated With Hypokalemic Periodic Paralysis in a Chinese Family.

Frontiers in genetics
2023

Catheter ablation of frequent monomorphic ventricular arrhythmias in Andersen-Tawil syndrome: case report and focused literature review.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
2022

Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes.

Neurogenetics
2021

Genetic Screening of Patients with Thyrotoxic Hypokalemic Periodic Paralysis: An Experience from a Tertiary Care Hospital in the Northeast of Brazil.

Endocrine, metabolic & immune disorders drug targets
2021

Gating pore currents occur in CaV1.1 domain III mutants associated with HypoPP.

The Journal of general physiology
2021

p.Asn1180Ile mutation of SCN4A gene in an Italian family with myopathy and myotonic syndrome.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

Confirming Genetic Abnormalities of Hypokalemic Periodic Paralysis Using Next-Generation Sequencing: A Case Report and Literature Review.

Electrolyte & blood pressure : E & BP
2021

Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy.

Cells
2021

Autophagy is affected in patients with hypokalemic periodic paralysis: an involvement in vacuolar myopathy?

Acta neuropathologica communications
2021

Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations.

Neuromuscular disorders : NMD
2021

The mechanism underlying transient weakness in myotonia congenita.

eLife
2021

Sodium channelopathies of skeletal muscle and brain.

Physiological reviews
2021

Pain as a significant symptom in patients with periodic paralysis-A cross-sectional survey.

Muscle & nerve
2021

Emergence and molecular characterization of pigeon Paramyxovirus-1 in non-native Eurasian collared doves (Streptopelia decaocto) in California, USA.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
2021

Exercise test for patients with new-onset paroxysmal kinesigenic dyskinesia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients.

Neuromuscular disorders : NMD
2021

Skeletal muscle channelopathies: a guide to diagnosis and management.

Practical neurology
2021

Co-existence of Congenital Adrenal Hyperplasia and Familial Hypokalemic Periodic Paralysis due to CYP21A2 and SCN4A Pathogenic Variants.

Journal of clinical research in pediatric endocrinology
2021

Distinctive facial features in Andersen-Tawil syndrome: A three-dimensional stereophotogrammetric analysis.

American journal of medical genetics. Part A
2021

The clinical and genetic heterogeneity analysis of five families with primary periodic paralysis.

Channels (Austin, Tex.)
2020

[A novel mutation of SCN4A gene causes hypokalemic periodic paralysis in a Chinese family].

Zhonghua yi xue za zhi
2021

Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.

Journal of neuromuscular diseases
2021

Obstetric management of a patient with Andersen-Tawil syndrome: A case report.

The journal of obstetrics and gynaecology research
2021

Familial periodic paralysis associated with a rare KCNJ5 variant that supposed to have incomplete penetrance.

Brain & development
2020

Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature.

Skeletal muscle
2021

The prevalence of hereditary neuromuscular disorders in Northern Norway.

Brain and behavior
2020

Morphological Alterations of the Sarcotubular System in Permanent Myopathy of Hereditary Hypokalemic Periodic Paralysis with a Mutation in the CACNA1S Gene.

Journal of neuropathology and experimental neurology
2020

Genome-wide meta-analysis reveals novel susceptibility loci for thyrotoxic periodic paralysis.

European journal of endocrinology
2020

CACNA1S Arg528Cys mutation in a young Chinese man with thyrotoxic hypokalemic periodic paralysis.

Clinical case reports
2020

[Hypokalemic periodic paralysis: a systematic review of published case reports].

Revista de neurologia
2020

Andersen-Tawil Syndrome with High Risk of Sudden Cardiac Death in Four Mexican Patients. Cardiac and Extra-Cardiac Phenotypes.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
2020

Primary Hypokalemic Periodic Paralysis: Long-term Management and Complications in a Child.

Journal of pediatric neurosciences
2020

Identification of a SCN4A mutation in a large Chinese family with atypical normokalemic periodic paralysis using whole-exome sequencing.

The Journal of international medical research
2021

Successful treatment of arrhythmia with β-blocker and flecainide combination in pregnant patients with Andersen-Tawil syndrome: A case report and literature review.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2020

Vacuoles, Often Containing Glycogen, Are a Consistent Finding in Hypokalemic Periodic Paralysis.

Journal of neuropathology and experimental neurology
2021

Andersen-Tawil Syndrome: A Comprehensive Review.

Cardiology in review
2020

Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients.

Frontiers in neurology
2020

Association study in Mexican patients with thyrotoxic hypokalemic periodic paralysis.

Biomedical reports
2020

Skeletal Muscle Channelopathies.

Neurologic clinics
2020

Mutation spectrum and health status in skeletal muscle channelopathies in Japan.

Neuromuscular disorders : NMD
2020

An unusual case of recurrent episodes of muscle weakness: Co-occurrence of Andersen-Tawil syndrome and glycogen storage disease type IXd.

Neuromuscular disorders : NMD
2020

Improving genetic diagnostics of skeletal muscle channelopathies.

Expert review of molecular diagnostics
2020

Managing pregnancy and anaesthetics in patients with skeletal muscle channelopathies.

Neuromuscular disorders : NMD
2020

Concurrent sodium channelopathies and amyotrophic lateral sclerosis supports shared pathogenesis.

Amyotrophic lateral sclerosis & frontotemporal degeneration
2020

First-Onset Hypokalemic Periodic Paralysis Following Surgery for Myxopapillary Ependymoma.

World neurosurgery
2020

Permanent muscle weakness in hypokalemic periodic paralysis.

Neurology
2020

"Electrifying dysmorphology": Potassium channelopathies causing dysmorphic syndromes.

Advances in genetics
2020

[Clinical and genetic analysis of a patient with Gitelman syndrome misdiagnosed as hypokalemic periodic paralysis].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2020

A role for external Ca2+ in maintaining muscle contractility in periodic paralysis.

The Journal of general physiology
2020

Myotonia congenita and periodic hypokalemia paralysis in a consanguineous marriage pedigree: Coexistence of a novel CLCN1 mutation and an SCN4A mutation.

PloS one
2020

A new clinical entity in T704M mutation in periodic paralysis.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2020

"Status myotonicus" in Nav1.4-M1592V channelopathy.

Neuromuscular disorders : NMD
2020

BK channel openers NS1619 and NS11021 reverse hydrogen peroxide-induced membrane potential changes in skeletal muscle.

Journal of receptor and signal transduction research
2020

Changes of Resurgent Na+ Currents in the Nav1.4 Channel Resulting from an SCN4A Mutation Contributing to Sodium Channel Myotonia.

International journal of molecular sciences
2020

Analysis of the genetic background associated with sporadic periodic paralysis in Japanese patients.

Journal of the neurological sciences
2020

Further evidence for shared genetic susceptibility in both sporadic and Thyrotoxic periodic paralysis.

Journal of the neurological sciences
2020

Skeletal muscle CaV1.1 channelopathies.

Pflugers Archiv : European journal of physiology
2020

Myotonic Myopathy With Secondary Joint and Skeletal Anomalies From the c.2386C>G, p.L769V Mutation in SCN4A.

Frontiers in neurology
2020

The expanding phenotype of hypokalemic periodic paralysis in a Japanese family with p.Val876Glu mutation in CACNA1S.

Molecular genetics & genomic medicine
2020

Identification of a novel PYGM mutation in a McArdle disease patient misdiagnosed as hypokalemic periodic paralysis.

Journal of endocrinological investigation
2019

Phenotypic variability in a series of four pediatric patients with Andersen-Tawil syndrome: A Saudi experience.

International journal of pediatrics & adolescent medicine
2020

PharmGKB summary: very important pharmacogene information for CACNA1S.

Pharmacogenetics and genomics
2019

Episodic Muscle Disorders.

Continuum (Minneapolis, Minn.)
2019

Myotonia in a patient with a mutation in an S4 arginine residue associated with hypokalaemic periodic paralysis and a concomitant synonymous CLCN1 mutation.

Scientific reports
2019

SCN4A p.R675Q Mutation Leading to Normokalemic Periodic Paralysis: A Family Report and Literature Review.

Frontiers in neurology
2019

Functional analysis of a double-point mutation in the KCNJ2 gene identified in a family with Andersen-Tawil syndrome.

Journal of the neurological sciences
2020

A zebrafish model of nondystrophic myotonia with sodium channelopathy.

Neuroscience letters
2020

Genetic Epidemiology Reveals 3 Chronic Reservoir Areas With Recurrent Population Mobility Challenging Poliovirus Eradication in Pakistan.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2019

A Novel De Novo Heterozygous SCN4a Mutation Causing Congenital Myopathy, Myotonia and Multiple Congenital Anomalies.

Journal of neuromuscular diseases
2020

Electromyographic Features in a Chinese Cohort With Hereditary Skeletal Muscle Channelopathies.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
2019

Clinical and neurophysiological variability in Andersen-Tawil syndrome.

Muscle & nerve
2019

Whole exome sequencing identified a heterozygous KCNJ2 missense variant underlying autosomal dominant familial hypokalemic periodic paralysis in a Pakistani family.

Journal of pediatric endocrinology & metabolism : JPEM
2019

[Analysis of SCN4A gene variation in a Chinese pedigree affected with skeletal muscle sodium channelopathies].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2019

Hypokalemic periodic paralysis due to CACNA1S gene mutation.

Neurosciences (Riyadh, Saudi Arabia)
2019

Contribution of Asian Haplotype of KCNJ18 to Susceptibility to and Ethnic Differences in Thyrotoxic Periodic Paralysis.

The Journal of clinical endocrinology and metabolism
2019

Usefulness of the intravenous flecainide challenge test before oral flecainide treatment in a patient with Andersen-Tawil syndrome.

BMJ case reports

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Paralisia periódica genética.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Paralisia periódica genética

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. The importance of comprehensive diagnostic work-up and genetic testing to reveal Andersen-Tawil syndrome-a case report.
    European heart journal. Case reports· 2026· PMID 41696039mais citado
  2. Case Report of Andersen-Tawil Syndrome: Rare Presentation of a Rare Disease.
    Annals of Indian Academy of Neurology· 2026· PMID 41643185mais citado
  3. Novel CACNA1S Mutation c.3491 A>C in Hypokalemic Periodic Paralysis: First Report with Functional Validation.
    Journal of molecular neuroscience : MN· 2026· PMID 41634283mais citado
  4. Sex determination and genetic screening of equine embryos with whole genome amplification and real-time PCR.
    The Journal of reproduction and development· 2026· PMID 41866194mais citado
  5. Clinical features and advances in the genetics of periodic paralysis.
    PeerJ· 2026· PMID 41800133mais citado
  6. Efficacy of a K(+) Channel Agonist, XEN1101, For Preserving Contractility in Mouse Models of Hypokalemic Periodic Paralysis.
    Muscle Nerve· 2026· PMID 41562289recente
  7. Efficacy of Retigabine in Treating Weakness in a Mouse Model of Hypokalemic Periodic Paralysis.
    Muscle Nerve· 2026· PMID 41550072recente
  8. Thyrotoxic Hypokalemic Periodic Paralysis: Pathophysiological Mechanisms.
    Endocrinol Metab (Seoul)· 2025· PMID 41376301recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:371433(Orphanet)
  2. MONDO:0000995(MONDO)
  3. GARD:21613(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q1788314(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Paralisia periódica genética
Compêndio · Raras BR

Paralisia periódica genética

ORPHA:371433 · MONDO:0000995
CID-11
MedGen
UMLS
C0030443
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades